Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease

Fractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration

(2015) Kevin R Nash et al.   MOLECULAR THERAPY

Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models

(2014) Sivaraman Purushothuman et al.   Alzheimers Research & Therapy

Therapeutic prospects for Parkinson disease

(2013) C. Warren Olanow et al.   ANNALS OF NEUROLOGY

The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of parkinsonism

(2013) Sivaraman Purushothuman et al.   BRAIN RESEARCH

Effect of red and near-infrared wavelengths on low-level laser (light) therapy-induced healing of partial-thickness dermal abrasion in mice

(2013) Asheesh Gupta et al.   LASERS IN MEDICAL SCIENCE

α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease

(2013) Stephen Mullin et al.   MOLECULAR NEUROBIOLOGY

Advances in the genetics of Parkinson disease

(2013) Joanne Trinh et al.   Nature Reviews Neurology

Genetics of Parkinson's disease: the yield

(2013) Marianna Spatola et al.   PARKINSONISM & RELATED DISORDERS

Near-Infrared 808 nm Light Boosts Complex IV-Dependent Respiration and Rescues a Parkinson-Related pink1 Model

(2013) Melissa Vos et al.   PLoS One

Polo-like kinase 2 regulates selective autophagic  -synuclein clearance and suppresses its toxicity in vivo

(2013) A. Oueslati et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease

(2012) M. Decressac et al.   EXPERIMENTAL NEUROLOGY

Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human  -Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease

(2012) A. Oueslati et al.   JOURNAL OF NEUROSCIENCE

The many faces of α-synuclein: from structure and toxicity to therapeutic target

(2012) Hilal A. Lashuel et al.   NATURE REVIEWS NEUROSCIENCE

Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson’s disease

(2012) Cassandra Peoples et al.   PARKINSONISM & RELATED DISORDERS

The Nuts and Bolts of Low-level Laser (Light) Therapy

(2011) Hoon Chung et al.   ANNALS OF BIOMEDICAL ENGINEERING

Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease

(2011) Alzbeta Trancikova et al.   ANTIOXIDANTS & REDOX SIGNALING

Current approaches to the treatment of Parkinson’s disease

(2011) Joseph Jankovic   Neuropsychiatric Disease and Treatment

Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits  -Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions

(2010) K. E. Paleologou et al.   JOURNAL OF NEUROSCIENCE

Missing pieces in the Parkinson's disease puzzle

(2010) Jose A Obeso et al.   NATURE MEDICINE

Mitochondrial Mechanisms of Photobiomodulation in Context of New Data About Multiple Roles of ATP

(2010) Tiina Karu   PHOTOMEDICINE AND LASER SURGERY

α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra

(2010) Alison L. McCormack et al.   PLoS One

Biphasic Dose Response in Low Level Light Therapy

(2009) Ying-Ying Huang et al.   Dose-Response

Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment

(2009) Victoria E. Shaw et al.   JOURNAL OF COMPARATIVE NEUROLOGY

Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent  -Synuclein Oligomer Formation and Rescue  -Synuclein-Induced Toxicity

(2009) P. Putcha et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS